ESC 365 - Professor Elaine Hylek

Speaker illustration

Professor Elaine Hylek

Boston University, Boston (United States of America)

Elaine M. Hylek, MD, MPH, is a Professor of Medicine at Boston University School of Medicine. She received her MD from the University of Pittsburgh School Of Medicine and a Masters in Public Health (quantitative methods) from Harvard University. She completed her residency training in internal medicine at Massachusetts General Hospital and Harvard Medical School in Boston, Massachusetts. Her research areas include arterial (stroke) and venous thrombosis, anticoagulant therapies, and atrial fibrillation. She has served as PI on several NIH grants, Executive Steering Committees for international trials and registries, Event Adjudication Committees, Guideline Committees, and Data Safety Monitoring Boards. She has also served as the Late Breaking Clinical Trial Discussant for multiple trials in the field of thrombosis. Dr. Hylek is a former Section Editor for Thrombosis and Haemostasis, and a founding member of the International Society of Thrombosis and Haemostasis World Thrombosis Day.

Sessions Presentations

Practical dilemmas in atrial fibrillation therapies

Event: ESC Congress 2024

Topic: Treatment

Session type: Advances in Science

Atrial fibrillation management and outcomes in high-risk atrial fibrillation populations

Event: ESC Congress 2024

Topic: Atrial Fibrillation (AF)

Session type: Abstract Sessions

Ask the Trialists from Hot Line 6

Event: ESC Congress 2024

Topic: European Society of Cardiology

Session type: Ask the Trialists

Management of atrial fibrillation: knowns and unknowns

Event: ESC Congress 2024

Topic: Treatment

Session type: Symposium

Atrial fibrillation and comorbidities: practical guidance for optimising stroke prevention

Event: ESC Congress 2022

Topic: Stroke Prevention

Session type: Satellite Symposium

Atrial fibrillation patients in focus: clinical cases and guidelines

Event: ESC Congress 2020

Topic: Stroke Prevention

Session type: Industry Q&A session

Antithrombotic therapy for coronary artery disease: opportunities and challenges

Event: ESC Congress 2019

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Advances in Science

10 years since RE-LY: applying innovations in anticoagulation

Event: ESC Congress 2019

Topic: Atrial Fibrillation (AF)

Session type: Satellite Symposium - Experts on the Spot

Identifying and managing complications of atrial fibrillation

Event: ESC Congress 2019

Topic: Treatment

Session type: Moderated Posters

Anticoagulation and your atrial fibrillation patients: bringing it all together in clinical practice

Event: ESC Congress 2018

Topic: Atrial Fibrillation (AF)

Session type: Satellite Symposium

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources